FROM:
Neurology 2003 (Jul 22); 61 (2): 160–164 ~ FULL TEXT
J.A. Zwart, MD, PhD; G. Dyb, MD; K. Hagen, MD, PhD;
S. Svebak, PhD; and J. Holmen, MD, PhD
Department of Clinical Neuroscience,
Faculty of Medicine,
Norwegian University of Science and Technology,
Trondheim.
john-anker.zwart@medisin.ntnu.no
OBJECTIVE: To examine the relation between analgesic use at baseline and the subsequent risk of chronic pain (> or =15 days/month) and the risk of analgesic overuse.
METHODS: In total, 32, 067 adults reported the use of analgesics in 1984 to 1986 and at follow-up 11 years later (1995 to 1997). The risk ratios (RR) of chronic pain and RR of analgesic overuse in the different diagnostic groups (i.e., migraine, nonmigrainous headache, neck pain, and low-back pain) were estimated in relation to analgesic consumption at baseline.
RESULTS: Individuals who reported use of analgesics daily or weekly at baseline showed significant increased risk for having chronic pain at follow-up. The risk was most evident for chronic migraine (RR = 13.3, 95% CI: 9.3 to 19.1), intermediate for chronic nonmigrainous headaches (RR = 6.2, 95% CI: 5.0 to 7.7), and lowest for chronic neck (RR = 2.4, 95% CI: 2.0 to 2.8) or chronic low-back (RR = 2.3, 95% CI: 2.0 to 2.8) pain. Among subjects with chronic pain associated with analgesic overuse, the RR was 37.6 (95% CI: 21.3 to 66.4) for chronic migraine, 14.4 (95% CI: 10.4 to 19.9) for chronic nonmigrainous headaches, 7.1 for chronic neck pain (95% CI: 5.5 to 9.2), and 6.4 for chronic low-back pain (95% CI: 4.9 to 8.4). The RR for chronic headache (migraine and nonmigrainous headache combined) associated with analgesic overuse was 19.6 (95% CI: 14.8 to 25.9) compared with 3.1 (95% CI: 2.4 to 4.2) for those without overuse.
CONCLUSION: Overuse of analgesics strongly predicts chronic pain and chronic pain associated with analgesic overuse 11 years later, especially among those with chronic migraine.
From the FULL TEXT Article:
Background
Chronic headache (headache 15 days/month) associated
with medication overuse is commonly seen in
clinic-based populations, [1] and the majority of the patients
presenting with primary chronic daily headache
use analgesics on a daily or near-daily basis. [2–4] Potentially
all analgesic drugs, including specific migraine
drugs, may lead to medication overuse headache
(MOH). [5] A survey among family doctors in the USA
reported MOH as the third most common cause of
headache. [6] In cross-sectional population-based studies,
the prevalence of MOH is estimated at 1 to 2%. [7–10]
Although cross-sectional epidemiologic data provide
prevalence estimates and associations, factors that
might influence headache prognosis must be evaluated
in longitudinal prospective study designs. To our
knowledge, only two population-based follow-up studies
have evaluated headache risk among chronic headache
sufferers, indicating that continuation of
analgesic overuse might be a significant predictor of
persistent chronic daily headache. [8, 12] Large prospective
population-based studies assessing the association between
analgesic overuse and the subsequent risk of
chronic pain and MOH have not yet been published.
The main purpose of the current prospective
population-based study was to examine the relationship
between analgesic overuse reported in 1984 to
1986 and the risk for having chronic headache (migraine
and nonmigrainous headache) and chronic
headache associated with analgesic overuse at
follow-up 11 years later (1995 to 1997). In addition,
for comparison, this relationship was also examined
for other common chronic pain conditions like
chronic neck and chronic low-back pain.
Discussion.
This study demonstrates that there
was a significantly increased risk of having chronic
pain and especially chronic pain associated with analgesic
overuse among those who reported daily or
weekly use of analgesics 11 years prior to endpoint
registration. The risk for chronic headache associated
with medication overuse was more than six
times higher than the risk for chronic headache
without medication overuse. These results are in accordance
with two population-based follow-up studies, reporting that analgesic overuse predicted the
persistence of chronic daily headache. [8, 10]
Patients with MOH usually have a history of episodic
migraine that has been transformed into
chronic headache as a result of medication overuse. [20]
Patients with tension-type headache may also overuse
medication, but this headache type is a less frequent
cause of MOH than migraine. [21] It is not
unlikely that other factors may contribute to the development
of chronic tension-type headache [22] and that
the drug use is associated rather than the cause. Approximately
80% of the subjects with nonmigrainous
headache in the current study had tension-type headache, [17] and although the RR for chronic nonmigrainous
headache associated with analgesic overuse was significantly
less than that for chronic migraine, it was significantly
higher than the RR for chronic neck or
chronic low-back pain. The co-occurrence of headache
and musculoskeletal symptoms may partly explain the
increased RR for neck and low-back pain. [23] There was
a reduction of the RR for neck pain associated with
analgesic overuse from 7.1 to 4.9 (95% CI: 3.8 to 6.3)
when the analyses were adjusted for coexisting headache.
The RR reduction was not that marked for lowback
pain, that is, from 6.4 to 5.1 (95% CI: 3.8 to 6.7),
which corresponds with our previous findings that
headache is more strongly associated with neck than
low-back pain. [23] The increased RR for analgesic overuse
at follow-up among subjects with chronic neck and
chronic low-back pain may reflect a sustained need for
pain-relieving medication due to the degenerative nature
of these disorders. Another plausible explanation
is that analgesic overuse may induce alterations in nociceptive
neural networks, which also would apply for
those with chronic headache. [24] There are both supportive
arguments and arguments against a causal relationship
between analgesic overuse and chronic
headache. [25] The substantial increase in RR among
those with chronic headache compared with those with
chronic neck or chronic low-back pain indicates, however,
that headache patients are more prone to develop
analgesic overuse, especially those with migraine. It
seems that patients without a history of headache taking
analgesics on a regular basis for other conditions do
not develop chronic daily headache. [26]
The strengths of this study were the large and
unselected population, the long follow-up period (11
years), and the use of validated endpoint registrations.
When interpreting the results of the current
study, several limitations must, however, be taken
into account. The questionnaire-based headache
diagnoses were not optimal compared with the interview
diagnoses. [17] The bias caused by misclassification
can either exaggerate or underestimate the true
difference between headache groups. Most likely, the
difference between migraine and nonmigrainous
headache sufferers is underestimated owing to the
presence of migraine subjects in the nonmigrainous
headache group and vice versa, making the two
groups more similar than they really are. The impact
of nonparticipants has been discussed in more detail
previously, [12] and the fact that neither headache nor
analgesic use was the primary objective of the study
makes selective participation unlikely. In addition,
the prevalence of migraine in the current population
is consistent with data from other population-based
studies in the Western countries. [12]
It must also be pointed out that this study does
not provide information about the type of analgesics
used or the use of other pain-moderating substances
at baseline. It is well documented, however, that
over-the-counter medications are the most commonly
used drugs among headache sufferers. [27] This has
also been found in a Norwegian study, where only a
minority of the patients with chronic headache used
specific migraine drugs. [28] The reported drugs leading
to MOH vary considerably between different studies,
and it is often difficult to identify one single substance
because most patients use more than one
compound. [28] Furthermore, the mean critical duration
until onset of MOH and the duration of withdrawal
headache after overuse vary: shortest for triptans,
intermediate for ergot alkaloids, and longest for analgesics. [5, 29] Another aspect is the exposure assessment,
where, because of statistical considerations,
patients in HUNT-1 reporting weekly use of analgesics
were combined with daily users. In addition,
patients in HUNT-2 that reported not using analgesics
daily or almost daily may have been using analgesics
occasionally. These factors could have resulted
in an underestimation of the RR observed.
In the current study, the headache status at the
time of analgesic use registration was unknown, and
so was the reason why the subjects used analgesics.
It is likely, however, that most people used analgesics
owing to headache at baseline. In a population-based
study in Tromsø, Norway, in 1986 to 1987,
19,137 individuals were asked about their use of analgesics.
On average, 28% of the women and 13% of
the men had used analgesics the preceding 14 days.
The most significant predictor was headache, which
was far more common than other types of physical
distress such as neckache, backache, and infections. [30] Finally, it is not known whether these individuals
continued their analgesic consumption
during the 11–year follow-up period. Most people,
however, experience their onset of headaches during
early adulthood, and among those with neck or lowback
pain in the current study, the mean duration of
pain was 11 and 13 years. If individuals reduced or
increased their use of analgesics after baseline, this
would result in an underestimation rather than an
overestimation of the relationship. Thus, it seems
reasonable to assume that the results from this
study do reflect a true relation between analgesic
overuse and subsequent pain.